Mesenchymal Stem Cells Market, [By Source (Bone Marrow, Umbilical Cord Blood, Peripheral Blood, Lung Tissue, Synovial Tissues, Amniotic Fluids, Adipose Tissues); By Application (Injuries, Drug Discovery, Cardiovascular Infraction, Others); By Region]: Market Size & Forecast, 2018 – 2026

Table of Contents

1. Overview and Scope
   1. Research goal & scope
   2. Research assumptions
   3. Research Methodology
      1. Primary data sources
      2. Secondary data sources
   4. Key take-away
   5. Stakeholders
2. Executive Summary
   1. Market Definition
   2. Market Segmentation
3. Mesenchymal Stem Cells Market Insights
   1. Mesenchymal Stem Cells – Industry snapshot
   2. Mesenchymal Stem Cells - Ecosystem analysis
   3. Mesenchymal Stem Cells Market Dynamics
      1. Mesenchymal Stem Cells – Market Forces
      2. Mesenchymal Stem Cells Market Driver Analysis
      3. Mesenchymal Stem Cells Market Restraint/Challenges analysis
      4. Mesenchymal Stem Cells Market Opportunity Analysis
   4. Industry analysis - Porter's five force
      1. Bargaining power of supplier
      2. Bargaining power of buyer
      3. Threat of substitute
      4. Threat of new entrant
      5. Degree of competition
   5. Mesenchymal Stem Cells Market PEST Analysis
   6. Mesenchymal Stem Cells Market Value Chain Analysis
   7. Mesenchymal Stem Cells Industry Trends
   8. Competitive Ranking Analysis
4. 间充质干细胞市场规模和预测Source Type, 2018-2026
   1. Key Findings
   2. Bone Marrow
   3. Umbilical Cord Blood
   4. Peripheral Blood
   5. Lung Tissue
   6. Synovial Tissues
   7. Amniotic Fluids
   8. Adipose Tissues.
5. 间充质干细胞市场规模和预测Application Type, 2018-2026
   1. Key Findings
   2. Injuries
   3. Drug Discovery
   4. Cardiovascular Infraction
   5. Others
6. 间充质干细胞市场规模和预测Region, 2018-2026
   1. Key Findings
   2. North America
      1. U. S.
      2. Canada
   3. Europe
      1. Germany
      2. UK
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
   4. Asia-Pacific
      1. China
      2. India
      3. Japan
      4. Singapore
      5. Malaysia
      6. Australia
      7. Rest of Asia-Pacific
   5. Latin America
      1. Mexico
      2. Brazil
      3. Argentina
      4. Rest of LATAM
   6. Middle East & Africa
7. Company Profiles
   1. Cell Applications, Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   2. Cyagen Biosciences Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   3. Axol Bioscience Ltd.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   4. Cytori Therapeutics Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   5. Stem cell technologies Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   6. Celprogen, Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   7. BrainStorm Cell Therapeutics.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments
   8. Stemedica Cell Technologies, Inc.
      1. Overview
      2. Financials
      3. Product Benchmarking
      4. Recent Developments